These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8351532)

  • 1. Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus--the case of Belgium.
    Tormans G; Van Damme P; Carrin G; Clara R; Eylenbosch W
    Soc Sci Med; 1993 Jul; 37(2):173-81. PubMed ID: 8351532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
    Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
    Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis.
    Prabhu M; Susich MK; Packer CH; Hersch AR; Riley LE; Caughey AB
    Obstet Gynecol; 2022 Mar; 139(3):357-367. PubMed ID: 35115449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
    Arevalo JA; Washington AE
    JAMA; 1988 Jan; 259(3):365-9. PubMed ID: 2961895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis.
    Devine A; Harvey R; Min AM; Gilder MET; Paw MK; Kang J; Watts I; Hanboonkunupakarn B; Nosten F; McGready R
    BMC Infect Dis; 2017 Aug; 17(1):552. PubMed ID: 28793866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of antenatal hepatitis B screening and vaccination of infants.
    Thomas IL
    Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):331-5. PubMed ID: 2150586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M; Detsky AS
    Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions.
    Zhao Y; Zhang X; Zhu F; Jin H; Wang B
    Hum Vaccin Immunother; 2016 Aug; 12(8):2003-2009. PubMed ID: 26900799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis].
    Zhang SX
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):154-8. PubMed ID: 1395956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.
    Jakiche R; Borrego ME; Raisch DW; Gupchup GV; Pai MA; Jakiche A
    Am J Med Sci; 2007 Jan; 333(1):26-34. PubMed ID: 17220691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis.
    Rossi C; Schwartzman K; Oxlade O; Klein MB; Greenaway C
    PLoS One; 2013; 8(10):e78548. PubMed ID: 24205255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine prenatal screening of Indian women for HBsAg: benefits derived versus cost.
    Sriprakash I; Anil TP
    Trop Doct; 1997 Jul; 27(3):176-7. PubMed ID: 9227020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women.
    Rours GI; Smith-Norowitz TA; Ditkowsky J; Hammerschlag MR; Verkooyen RP; de Groot R; Verbrugh HA; Postma MJ
    Pathog Glob Health; 2016; 110(7-8):292-302. PubMed ID: 27958189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness.
    Da Villa G; Sepe A
    Vaccine; 1999 Mar; 17(13-14):1734-8. PubMed ID: 10194831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
    Mulley AG; Silverstein MD; Dienstag JL
    N Engl J Med; 1982 Sep; 307(11):644-52. PubMed ID: 6810170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.